Literature DB >> 31391715

Non-HDL as a Valid Surrogate Marker of Small Dense LDL in a Young Indian Population.

Anjali Manocha1, Seema Bhargava1, Rajneesh Jain2, Mamta Kankra1, Parul Singla1, Parul Chugh3.   

Abstract

Small dense (sd) LDL is a significant independent risk factor for premature coronary artery disease (CAD). Unfortunately, its estimation is not popular, due to the limited availability of specialized equipment, high cost and time-consuming technique. Non-HDL is a calculated, single index measure of all atherogenic apolipoprotein-B containing lipoproteins. This study aimed at identifying non-HDL as a superior surrogate marker of sdLDL cholesterol in a young Indian population. 161 healthy subjects < 45 years were tested for lipid profile, apolipoproteins A1 and B, and sdLDL particle size. sdLDL particles showed negative correlation with non-HDL (r = - 0.283, p < 0.001), LDL (r = - 0.195, p = 0.013) and apoB/apo A1 (r = - 0.175, p = 0.026), the significance being greatest with non-HDL. ROC showed AUC for non-HDL, LDL and apoB/apo A1 as 0.704, 0.686, and 0.596 respectively. For LDL < 130 mg/dL, sdLDL showed a more significant negative correlation with non-HDL (r = - 0.291, p < 0.001) as compared with apoB/apoA1 (r = - 0.172, p = 0.037). For triglycerides < 200 mg/dL, sdLDL particle size showed higher significant negative correlation with non-HDL (r = - 0.213, p = 0.015) than with LDL (r = - 0.176, p = 0.045) while for triglycerides between 200 and 400 mg/dL, significant negative correlation was observed only with non-HDL (r = - 0.372, p = 0.043). Hence, our study suggested that non-HDL is a superior surrogate marker of sdLDL particle size as compared to LDL and apoB/A1 ratio in a young healthy Indian population and should be used for optimum assessment of dyslipidemias and CAD risk.

Entities:  

Keywords:  Apolipoproteins; Non-HDL; Premature coronary artery disease; Risk factors; Small dense LDL

Year:  2018        PMID: 31391715      PMCID: PMC6660532          DOI: 10.1007/s12291-018-0758-6

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  31 in total

Review 1.  Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects.

Authors:  S H Gianturco; W A Bradley
Journal:  Clin Cardiol       Date:  1999-06       Impact factor: 2.882

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.

Authors:  Scott M Grundy
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

4.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

5.  Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method.

Authors:  Tsutomu Hirano; Yasuki Ito; Shinji Koba; Miwako Toyoda; Ayako Ikejiri; Haruhisa Saegusa; Jun-ichi Yamazaki; Gen Yoshino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-15       Impact factor: 8.311

6.  Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.

Authors:  Annie C St-Pierre; Bernard Cantin; Gilles R Dagenais; Pascale Mauriège; Paul-Marie Bernard; Jean-Pierre Després; Benoît Lamarche
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-23       Impact factor: 8.311

7.  Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases.

Authors:  Shinji Koba; Tsutomu Hirano; Yasuki Ito; Fumiyoshi Tsunoda; Yuuya Yokota; Yoshihisa Ban; Yoshitaka Iso; Hiroshi Suzuki; Takashi Katagiri
Journal:  Atherosclerosis       Date:  2006-01-18       Impact factor: 5.162

8.  Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease.

Authors:  Shinji Koba; Tsutomu Hirano; Takeshi Kondo; Masayuki Shibata; Hiroshi Suzuki; Mikitaka Murakami; Eiichi Geshi; Takashi Katagiri
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

9.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.

Authors:  Y Cui; R S Blumenthal; J A Flaws; M K Whiteman; P Langenberg; P S Bachorik; T L Bush
Journal:  Arch Intern Med       Date:  2001-06-11

10.  VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass.

Authors:  Dragana Milosavljevic; Anatol Kontush; Sabine Griglio; Gilles Le Naour; Joëlle Thillet; M John Chapman
Journal:  Biochim Biophys Acta       Date:  2003-02-20
View more
  1 in total

1.  Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients.

Authors:  Gen Ouchi; Ichiro Komiya; Shinichiro Taira; Tamio Wakugami; Yusuke Ohya
Journal:  Lipids Health Dis       Date:  2022-01-07       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.